| data anonymisation |
data anonymisation (Research, paragraph 30)
|
for clinical audit (Confidentiality, paragraph 15)
|
|
| Data Protection Act 1998 |
Data Protection Act 1998 (Confidentiality FAQs, question 21)
|
Data Protection Act 1998 (Research, paragraph 30)
|
Data Protection Act 1998 (Management, paragraph 42)
|
|
| data protection legislation (Confidentiality, paragraph 1) |
| databases, guidance on setting up (Confidentiality FAQs, question 6) |
|
| death |
confidentiality after patient death (Good Medical Practice, paragraph 37)
|
disclosure of information after (Confidentiality, paragraph 30)
|
disclosure of information and risk of (Confidentiality, paragraph 10)
|
dying patients, care of (Withholding and Withdrawing, paragraph 26, 27)
|
discussion with (Withholding and Withdrawing, paragraph 27)
|
prolonging of dying in (Withholding and Withdrawing, paragraph 12)
|
end of natural life (Withholding and Withdrawing, paragraph 12)
|
prolonging of dying (Withholding and Withdrawing, paragraph 3)
|
provision of information on (Good Medical Practice, paragraph 69)
|
raising concerns when there is a risk of (Raising Concerns, paragraph 6)
|
refusal of treatment leading to (Withholding and Withdrawing, paragraph 13)
|
|
| decision-making |
by patients (Good Medical Practice, paragraph 21f)
|
in provision of information (Good Medical Practice, paragraph 66)
|
in treatment (Good Medical Practice, paragraph 7)
|
informed (Consent, paragraphs 1-3)
|
role of third-parties (Consent, paragraph 11)
|
voluntary (Consent, paragraphs 15-17)
|
where there is lack of information (Withholding and Withdrawing, paragraphs 39-40)
|
|
| delegation |
accountability and (Accountability in multi-disciplinary teams, paragraph 5)
|
by managers (Management, paragraph 17)
|
by psychiatrists (Accountability in multi-disciplinary teams, paragraph 6)
|
delegation (Good Medical Practice, paragraph 54)
|
management of training and feedback (Management, paragraph 38)
|
of responsibility (Management, paragraph 53)
|
|
| depression in colleagues (Management, paragraph 58) |
| design of research (Research, paragraphs 11-12) |
|
| diagnosis |
patient information and consent (Consent, paragraph 4)
|
provision of information (Confidentiality, paragraph 7)
|
|
| dialysis (Withholding and Withdrawing, paragraph 2) |
|
| disagreements |
consulting other clinicians when there is disagreement (Withholding and Withdrawing, paragraph 38)
|
on withholding or withdrawing care (Withholding and Withdrawing, paragraphs 34, 35)
|
resolving for best interests (Withholding and Withdrawing, paragraphs 58-59)
|
|
| disclosure of information |
after patient's death (Confidentiality, paragraph 30)
|
after patient's death (Confidentiality FAQs, questions 18-20)
|
children (Confidentiality, paragraph 28)
|
consent for research (Confidentiality FAQs, question 10)
|
for administrative purposes (Confidentiality FAQs, question 9)
|
for databases (Confidentiality FAQs, question 6)
|
for financial purposes (Confidentiality FAQs, question 9)
|
for public health monitoring (Confidentiality FAQs, question 7)
|
for recordings (Audio and Visual
Recordings, paragraph 14)
|
in clinical audit (Confidentiality, paragraphs 13-15)
|
in public interest (Confidentiality, paragraphs 22-26)
|
in public interest (Confidentiality FAQs, questions 14-17)
|
in public interest (Research, paragraphs 37-40)
|
in research (Research, paragraph 30)
|
in those who lack capacity (Confidentiality, paragraph 28)
|
law on (Confidentiality FAQs, question 21)
|
management of (Management, paragraph 42)
|
objections to (Confidentiality, paragraph 14)
|
patient's rights (Confidentiality, paragraph 1)
|
required by law (Confidentiality, paragraph 18)
|
statutory duty (Research, paragraph 36)
|
to courts (Confidentiality, paragraphs 19, 20)
|
to disease registers (Confidentiality FAQs, question 5)
|
to life insurance companies (Confidentiality FAQs, question 13)
|
to protect patient (Confidentiality, paragraph 27)
|
to statutory regulatory bodies (Confidentiality, paragraph 21)
|
unintentional (Confidentiality, paragraph 5)
|
use of existing records in research (Research, paragraphs 31-33)
|
warning of (Confidentiality, paragraph 25)
|
when consent cannot be obtained (Research, paragraph 34)
|
where patient is victim of neglect or abuse (Confidentiality, paragraph 29)
|
with express consent (Confidentiality, paragraphs 16-17)
|
with implied consent (Confidentiality, paragraphs 10-15)
|
within healthcare teams (Confidentiality, paragraphs 10-12)
|
|
| discrimination |
discrimination (Good Medical Practice, paragraph 46)
|
discrimination (Management, paragraph 47)
|
discrimination (Withholding and Withdrawing, paragraph 25)
|
in vulnerable adults (Research, paragraph 43)
|
|
| disease registers, disclosure of information to (Confidentiality FAQs, question 5) |
| dispensing, repeat (Prescribing, paragraphs 32-37) |
| DNAR order (Withholding and Withdrawing, paragraph 85) |
| doctor-patient partnership (Maintaining Boundaries, paragraphs 2-3) |
| doctor-patient relationship, importance of trust in (Conflicts of Interest, paragraph 2) |
| donations (Conflicts of Interest, paragraph 1) |
| double-blind trials (Research, paragraph 20) |
| driving, disclosure of information to DVLA (Confidentiality FAQs, paragraph 17) |
| drug dependence in colleagues (Management, paragraph 58) |
|
| drug licences |
prescribing outside terms of (Prescribing, paragraphs 19-20)
|
provision of information on (Prescribing, paragraphs 21-24)
|
|
| drug trials, consent for (Consent, paragraph 35) |
| duty of care, of managers (Management, paragraph 4) |
| DVLA, disclosure of information to (Confidentiality FAQs, question 17) |
|
| dying patients |
care of (Withholding and Withdrawing, paragraph 26, 27)
|
discussion with (Withholding and Withdrawing, paragraph 27)
|
prolonging of dying in (Withholding and Withdrawing, paragraph 12)
|